What GLP-1 drugs reveal about MPNs, inflammation, and cancer risk A surprising link between inflammation, clonal blood stem cells, and a blockbuster drug opens new questions in blood cancer research. In recent years, glucagon-like peptide-1 receptor agonists (GLP-1RAs) — the class of drugs that includes Ozempic, Wegovy, and others — transformed care for type 2… Read More »What GLP-1 Drugs Reveal About MPNs, Inflammation, and Cancer Risk 

What do megakaryocytes, machine learning, and a team of Oxford scientists have in common? They’re all part of Dr. Daniel Royston’s mission to teach computers how to see what pathologists might miss — the secret signs of fibrosis hiding in the bone marrow. In this month’s Researcher Spotlight, step inside a one-of-a-kind laboratory where engineers… Read More »How to train your AI model: Dr. Daniel Royston’s quest to decode the bone marrow 

Explaining a chronic cancer like an MPN to a child can feel overwhelming — especially when the symptoms aren’t always visible. In this new article, pediatric psychologist Dr. Joanna Patten shares expert advice on what to say and how to say it. Learn why late is better than never and how honest, age-appropriate conversations help… Read More »How to explain MPNs to children